| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ceccarelli G et al. | Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. | 2013 | Crit Care | pmid:23414732 |
| Hothersall JD et al. | Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization. | 2013 | Br. J. Pharmacol. | pmid:23581504 |
| Semis R et al. | Mechanism of activity and toxicity of Nystatin-Intralipid. | 2013 | Med. Mycol. | pmid:23088298 |
| Heneedak HM et al. | HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. | 2012 Nov-Dec | J Chromatogr Sci | pmid:22879356 |
| Alcântara CS et al. | Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. | 2012 Nov-Dec | J Appl Oral Sci | pmid:23329241 |
| Houlton JJ et al. | Intranasal drug-induced fungal rhinopharyngitis. | 2012 Mar-Apr | Int Forum Allergy Rhinol | pmid:22253034 |
| Shanmughapriya S et al. | In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. | 2012 | Biofouling | pmid:22963125 |
| Blyth CC et al. | Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. | 2012 | J Paediatr Child Health | pmid:22970680 |
| Silva MM et al. | Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22986242 |
| Kaomongkolgit R et al. | Antifungal activity of coronarin D against Candida albicans. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22727093 |
| Mima EG et al. | Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. | 2012 | Clin. Microbiol. Infect. | pmid:22731617 |
| Fernández Campos F et al. | Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. | 2012 | J Pharm Sci | pmid:22777575 |
| Kalema N et al. | Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. | 2012 | PLoS ONE | pmid:22808020 |
| Al-Dwairi ZN et al. | The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. | 2012 | J Prosthodont Res | pmid:22841909 |
| Caliceti C et al. | Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. | 2012 | PLoS ONE | pmid:22859971 |
| Kondo C et al. | Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. | 2012 | J Toxicol Sci | pmid:22863853 |
| Ouédraogo M et al. | Free radical scavenging capacity, anticandicidal effect of bioactive compounds from Sida cordifolia L., in combination with nystatin and clotrimazole and their effect on specific immune response in rats. | 2012 | Ann. Clin. Microbiol. Antimicrob. | pmid:23268761 |
| da Silva WJ et al. | Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents. | 2012 | Braz Dent J | pmid:23338267 |
| Shinde RB et al. | Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. | 2012 | Ann. Clin. Microbiol. Antimicrob. | pmid:23035934 |
| Hingston CD et al. | Impact of nystatin on Candida and the oral microbiome. | 2012 | Crit Care | pmid:22827886 |